Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Triangle Biotechnology, Inc. in August, 2020 for $252,131.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI152796-01A1 | Phase I | 252,131 | August 3, 2020 | |||||||
A SBIR Phase I contract was awarded to Triangle Biotechnology, Inc. in April, 2019 for $298,529.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43CA236177-01 | Phase I | 298,529 | April 9, 2019 | |||||||
A SBIR Phase II contract was awarded to Triangle Biotechnology, Inc. in May, 2022 for $1,000,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44AI152796-02 | Phase II | 1,000,000 | May 25, 2022 | |||||||
A SBIR Phase I contract was awarded to Triangle Biotechnology, Inc. in July, 2018 for $298,530.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43CA232902-01 | Phase I | 298,530 | July 5, 2018 | |||||||
A SBIR Phase I contract was awarded to Triangle Biotechnology, Inc. in February, 2020 for $225,000.0 USD from the National Science Foundation. | SBIR | 1938293 | Phase I | 225,000 | February 1, 2020 | |||||||
A SBIR Phase II contract was awarded to Triangle Biotechnology, Inc. in September, 2020 for $844,657.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44CA232902-02A1 | Phase II | 844,657 | September 8, 2020 | |||||||
A SBIR Phase I contract was awarded to Triangle Biotechnology, Inc. in August, 2023 for $339,300.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43GM150348-01 | Phase I | 339,300 | August 15, 2023 |